We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MYMX market cap is 301.74k. The company's latest EPS is EUR -0.1592 and P/E is -0.06.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 967k | 653k | 668k | 430k | 1.03M |
| Operating Income | -1.4M | -1.49M | -1.57M | -1.65M | -1.75M |
| Net Income | -4.17M | -4.19M | -4.16M | -4.73M | -4.81M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 7.81M | 7.68M | 8.1M | 7.63M | 7.32M |
| Total Liabilities | 54.83M | 58.88M | 63.45M | 67.72M | 72.22M |
| Total Equity | -47.03M | -51.2M | -55.35M | -60.09M | -64.9M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -2.31M | -972k | -1.7M | -1.7M | -1.69M |
| Investing | N/A | -36k | -14k | -10k | -2k |
| Financing | 1.6M | 1.2M | 2.11M | 1.2M | 1.44M |
| Market Cap | 301.74k |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 0.29 |
| Price to Cash Ratio | 0.96 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 30.17M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -99.93% |
| 52 Week High | 56.60 |
| 52 Week Low | 0.01 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Mymetics Corporation (CE) |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.mymetics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
